戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1               C9i also enhanced apoptosis in cord blood-derived CD19(+) B-lineage cells (but not myel
2           Human hematopoietic cell lines and cord blood-derived CD34(+) and CD34(+), CD38(-) cell pop
3 ression of the NUP98-HOXA9 fusion protein in cord blood-derived CD34(+) cells confers a proliferative
4           In vitro pDC generation from human cord blood-derived CD34(+) hematopoietic progenitors was
5 n immune system was generated from umbilical cord blood-derived CD34(+) hematopoietic stem cells in B
6  cooperates with MA4 to initiate leukemia in cord blood-derived CD34(+) hematopoietic stem/progenitor
7              EV treatment of human umbilical cord blood-derived CD34(+) HSPCs alters the expression o
8 f ligands for both P- and E-selectins on all cord blood-derived CD34+ cells.
9                                              Cord blood-derived CD4(+) T cells are largely naive and
10                     Comparison with expanded cord blood-derived CD4(+)CD25(hi) tTreg and expanded Tef
11 mbined with ex vivo expanded human umbilical cord blood-derived CD8(+) T cells, that have been geneti
12                                              Cord blood-derived cells surrounding surfactant-immunore
13 ransplanted lineage-depleted human umbilical cord blood-derived cells with high aldehyde dehydrogenas
14 Human LAD2 cells and umbilical primary human cord blood-derived cultured mast cells were stimulated w
15 d TNF from LAD2 cells and of CCL2 from human cord blood-derived cultured MCs.
16                                              Cord blood-derived cultured suppressor cell function was
17                           DNA methylation of cord-blood derived DNA from 134 infants involved in a pr
18                                              Cord blood-derived ECFC therapy may offer new therapeuti
19         Intrajugular administration of human cord blood-derived ECFCs after established arrested alve
20   We examined the effects of human umbilical cord blood-derived ECFCs and their extracellular vesicle
21 studies indicate protective effects of human cord blood-derived ECFCs in experimental AKI and suggest
22 deficient mice in the presence or absence of cord blood-derived ECFCs.
23 Cs, the endothelial layer consisted of human cord blood-derived endothelial progenitor cells (hCB-EPC
24 lating factor in cultures of human umbilical cord blood-derived eosinophil (CDE) precursor cells.
25                                    Umbilical cord blood-derived EPCs (cbEPCs) were analyzed in parall
26 generated by peripheral blood- and umbilical cord blood-derived EPCs in a model of in vivo vasculogen
27               However, similar to adult- and cord blood-derived EPCs, HUVECs and HAECs derived from v
28 racterized the dynamic adhesion of umbilical-cord-blood-derived EPCs (CB-EPCs) to surfaces coated wit
29                                    Umbilical cord blood-derived haematopoietic stem cells (HSCs) are
30 the stem cell activity of cultured umbilical cord blood derived hematopoietic cells.
31 splants by intrahepatic inoculation of human cord blood-derived hematopoietic progenitor cells (CD34(
32 ator of adhesive properties in primary human cord blood-derived hematopoietic stem and progenitor cel
33 udy, we genetically modified human umbilical cord blood-derived hematopoietic stem cells (HSCs) to ex
34 lts in a marked expansion of human umbilical cord blood-derived HSPCs following cytokine stimulation.
35                      We found that umbilical cord blood-derived HSPCs showed the greatest transplanta
36 nt CD34(+) erythroleukemic cell line, and in cord blood-derived human CD34(+) cells.
37 Rag2(-)/(-)gammac(-)/(-) mice humanized with cord blood-derived human hematopoietic stem cells produc
38 erism were observed after transplantation of cord blood-derived human HSCs into nonirradiated adult a
39 ulation of the human LAD2 mast-cell line and cord blood-derived human mast cells (hMCs).
40 adenine nucleotide-specific P2Y receptors on cord blood-derived human mast cells (hMCs).
41  Fc epsilon RI expression in these umbilical cord blood-derived human mast cells, as well as in mouse
42                                              Cord blood-derived human MC (hMC) express functional rec
43                                     Cultured cord blood-derived human MCs (hMCs) express mRNA transcr
44 sion and CysLT(1)-dependent proliferation of cord blood-derived human MCs (hMCs).
45    Moreover, preparations of human umbilical cord blood-derived immature mast cells not only expresse
46 TB(4) was a potent chemoattractant for human cord blood-derived immature, but not mature, mast cells.
47 s prolong VEGFR-2 and Akt phosphorylation in cord blood-derived late outgrowth endothelial progenitor
48 leukotriene C(4) synthase (LTC(4)S) by human cord blood--derived mast cells (hMCs), augments their hi
49                We now demonstrate that human cord blood-derived mast cell progenitors are susceptible
50  protease tryptase in normal human umbilical cord blood-derived mast cells (hCBMCs).
51 howed that the native MCEMP1 is expressed in cord blood-derived mast cells and HMC-1 and THP-1 cell l
52                                        Human cord blood-derived mast cells and the HMC-1 mast cell li
53 rkC, whereas preparations of human umbilical cord blood-derived mast cells expressed mRNAs for trkA a
54 e of the type I interferon receptor on human cord blood-derived mast cells reduced the RSV-mediated i
55 uman leukemic mast cells and human umbilical cord blood-derived mast cells to release newly synthesiz
56                                        Human cord blood-derived mast cells undergo apoptosis upon exp
57                                        Human cord blood-derived mast cells were treated for 2 weeks w
58 le development and function were examined in cord blood-derived mast cells.
59  mRNA and protein were present only in human cord blood-derived mast cells.
60 c mast cell (HMC-1) line and human umbilical cord blood-derived mast cells.
61 ergic donors' basophils and sensitized human cord blood-derived mast cells.
62 s IgE-desensitized rat MC and human lung and cord blood-derived MC (CBMC) after priming with fibrobla
63           S1P accelerated the development of cord blood-derived MCs (CB-MCs) and strikingly increased
64            The LAD2 MC line or primary human cord blood-derived MCs (CBMCs) were infected with HRV or
65                     We now report that human cord-blood-derived MCs (hMCs) express the CysLT1 recepto
66 nduction were similar to levels achieved for cord blood-derived MPP and up to 20-fold higher than tho
67  adoptive transfer of ex vivo expanded human cord blood-derived NK cells into humanized mice reconsti
68 w Notch influences terminal differentiation, cord blood-derived NK cells or sorted peripheral blood N
69         Overexpression of activated Notch on cord blood-derived NK cells resulted in a 2-fold increas
70 lthy donors were cultured in the presence of cord blood-derived normal AFP (nAFP) or HCC tumor-derive
71                           MCs developed from cord blood-derived progenitors cultured with stem cell f
72 rily focused on the more extensively studied cord blood-derived stem cell.
73      CD8+,CD57+ T cells were cocultured with cord blood-derived stem cells, and percentage inhibition
74  the growth of normal cells, including human cord blood-derived stem cells.
75  hairpin RNA (shRNA) library transduced into cord blood-derived stem/progenitor cells.
76                                              Cord blood-derived surfactant-positive epithelial cells
77 e expression of these receptors on adult and cord blood-derived term and preterm neonatal B cells.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。